$8 targetJanney Montgomery Scott
initiated coverage on shares of
Corcept Therapeutics Incorporated (NASDAQ
:CORT) in a report published on Thursday,
Market Beat reports. The brokerage issued a buy
rating and a $8.00 target
price on the stock.
Shares of Corcept Therapeutics (NASDAQ:CORT) traded up 1.63% on Thursday, reaching $4.98. 172,615 shares of the company were exchanged. The stock has a 50 day moving average of $4.80 and a 200-day moving average of $5.03. The company’s market capitalization is $541.70 million. Corcept Therapeutics has a 52-week low of $2.69 and a 52-week high of $7.67.
Corcept Therapeutics (NASDAQ:CORT) last released its quarterly earnings data on Thursday, November 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.01. During the same period in the previous year, the company earned ($0.06) EPS. The business earned $13.30 million during the quarter, compared to analyst estimates of $13.90 million. Corcept Therapeutics’s revenue was up 82.2% on a year-over-year basis. On average, analysts predict that Corcept Therapeutics will post ($0.09) EPS for the current fiscal year.
https://www.wkrb13.com/markets/961833/corcept-therapeutics-incorporated-cort-coverage-initiated-by-analysts-at-janney-montgomery-scott/